1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Lonza Group AG
  6. News
  7. Summary
    LONN   CH0013841017

LONZA GROUP AG

(LONN)
  Report
Delayed Swiss Exchange  -  11:31 2022-06-30 am EDT
509.00 CHF   +0.91%
06/26Lonza Signs License Deal With Adva Biotechnology For Automated Bioreactor-linked Patents
MT
06/24LONZA : and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bioreactors with License to Lonza's Patents
PU
06/15Lonza Group Signs Manufacturing Agreement With Pierre Fabre
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

LONZA GROUP AG : Ex-dividend day for final dividend

05/09/2022 EDT

A final dividend is removed today from Lonza Group AG's share.



© Factset 2022
All news about LONZA GROUP AG
06/26Lonza Signs License Deal With Adva Biotechnology For Automated Bioreactor-linked Patent..
MT
06/24LONZA : and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bior..
PU
06/15Lonza Group Signs Manufacturing Agreement With Pierre Fabre
MT
06/08Lonza Rolls Out PyroCell Monocyte Activation Test System For In Vitro Testing
MT
06/07LONZA : More Sensitive Non-endotoxin Pyrogen Detection Now Possible with Lonza's New PyroC..
PU
06/03AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..
MT
06/01Lonza Delivers Early Phase Clinical Manufacturing Facility in US
MT
06/01LONZA : Completes Dedicated Early Clinical Phase Development and Manufacturing Facility in..
PU
05/25Lonza and Israel Biotech Fund Collaboration Framework Agreement to Support Biologics an..
AQ
05/24Lonza Ties Up With Israel Biotech Fund On Biologics, Small Molecule Development, Manufa..
MT
More news
Analyst Recommendations on LONZA GROUP AG
More recommendations
Financials
Sales 2022 6 150 M 6 440 M 6 440 M
Net income 2022 1 068 M 1 118 M 1 118 M
Net cash 2022 255 M 267 M 267 M
P/E ratio 2022 35,4x
Yield 2022 0,65%
Capitalization 37 762 M 39 547 M 39 547 M
EV / Sales 2022 6,10x
EV / Sales 2023 5,43x
Nbr of Employees 16 218
Free-Float 99,6%
Chart LONZA GROUP AG
Duration : Period :
Lonza Group AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LONZA GROUP AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 509,00 CHF
Average target price 789,01 CHF
Spread / Average Target 55,0%
EPS Revisions
Managers and Directors
Pierre-Alain Ruffieux Chief Executive Officer
Philippe Deecke Chief Financial Officer
Albert M. Baehny Chairman
Stefan Stoffel Head-Small Molecules Exclusive Synthesis Operation
Barbara May Richmond Independent Director
Sector and Competitors
1st jan.Capi. (M$)
LONZA GROUP AG-33.77%39 234
MODERNA, INC.-43.77%56 804
IQVIA HOLDINGS INC.-24.11%40 527
SEAGEN INC.15.82%32 961
CELLTRION, INC.-9.85%18 726
ICON PUBLIC LIMITED COMPANY-29.85%17 663